Journal
TRIALS
Volume 11, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1745-6215-11-95
Keywords
-
Categories
Funding
- VA HSRD SDP [06-128]
- NIDDK [R18 DK076622-01A1]
- VA Diabetes Quality Enhancement DIB [98-001]
- Michigan Diabetes Research and Training Center [P60DK-20572]
- Michigan Institute for Clinical and Health Research [NIH UL1RR024986]
- Office of Research in Women's Health Building Interdisciplinary Careers in Women's Health [K12HD052163]
Ask authors/readers for more resources
Background: Many patients with diabetes have poor blood pressure (BP) control. Pharmacological therapy is the cornerstone of effective BP treatment, yet there are high rates both of poor medication adherence and failure to intensify medications. Successful medication management requires an effective partnership between providers who initiate and increase doses of effective medications and patients who adhere to the regimen. Methods: In this cluster-randomized controlled effectiveness study, primary care teams within sites were randomized to a program led by a clinical pharmacist trained in motivational interviewing-based behavioral counseling approaches and authorized to make BP medication changes or to usual care. This study involved the collection of data during a 14-month intervention period in three Department of Veterans Affairs facilities and two Kaiser Permanente Northern California facilities. The clinical pharmacist was supported by clinical information systems that enabled proactive identification of, and outreach to, eligible patients identified on the basis of poor BP control and either medication refill gaps or lack of recent medication intensification. The primary outcome is the relative change in systolic blood pressure (SBP) measurements over time. Secondary outcomes are changes in Hemoglobin A1c, low-density lipoprotein cholesterol (LDL), medication adherence determined from pharmacy refill data, and medication intensification rates. Discussion: Integration of the three intervention elements - proactive identification, adherence counseling and medication intensification - is essential to achieve optimal levels of control for high-risk patients. Testing the effectiveness of this intervention at the team level allows us to study the program as it would typically be implemented within a clinic setting, including how it integrates with other elements of care. Trial Registration: The ClinicalTrials.gov registration number is NCT00495794.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available